STOCK TITAN

Evaxion A/S (NASDAQ: EVAX) insider reports Form 3 share and warrant holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Evaxion A/S filed a Form 3 reporting initial holdings of its securities. The reporting person holds 645,750 Ordinary Shares directly. It also reports warrants that are exercisable into 322,850 Ordinary Shares at an exercise price of $0.0590 per share, expiring on January 31, 2030. A footnote explains these warrants were issued in connection with a public offering that closed on January 31, 2025.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Evaxion A/S

(Last)(First)(Middle)
DR. NEERGAARDS VEJ 5F

(Street)
HORSHOLMDK-2970

(City)(State)(Zip)

DENMARK

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Evaxion A/S [ EVAX ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares645,750D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrants(1)01/31/202501/31/2030Ordinary Shares322,850$0.059D
Explanation of Responses:
1. Warrants pursuant to public offering that closed 1/31/2025.
Remarks:
Exhibit List - Exhibit 24.1 Power of Attorney. This initial holding statement has been made for Thomas Frederik Schmidt using the Issuer's CIK codes to satisfy Form 3 filing requirements. An amendment will be filed for Mr. Schmidt upon receipt of his CIK filer codes from the SEC.
/s/ Michael Baird, Attorney-in-Fact03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Evaxion A/S (EVAX) Form 3 filing disclose?

The Form 3 discloses initial holdings of Evaxion A/S securities by the reporting person, including Ordinary Shares and warrants. It establishes the baseline ownership position, detailing both common equity and derivative exposure through warrants tied to future Ordinary Share issuance.

How many Evaxion A/S Ordinary Shares are reported on this Form 3?

The filing reports direct ownership of 645,750 Evaxion A/S Ordinary Shares. This figure represents the reporting person’s common equity position as of the Form 3 date and serves as the starting point for tracking future changes in beneficial ownership in later insider filings.

What warrant position related to Evaxion A/S Ordinary Shares is disclosed?

The Form 3 reports warrants exercisable for 322,850 Evaxion A/S Ordinary Shares. These warrants provide the right to acquire additional Ordinary Shares at a fixed exercise price, adding a significant derivative component to the reporting person’s overall economic exposure to Evaxion A/S equity.

What is the exercise price and expiry for the Evaxion A/S warrants?

The warrants are exercisable at an exercise price of $0.0590 per underlying Ordinary Share and expire on January 31, 2030. This long-dated structure gives the holder several years of optionality to convert warrants into equity at the stated price.

How were the reported Evaxion A/S warrants originally issued?

A footnote states the warrants were issued pursuant to a public offering that closed on January 31, 2025. This indicates the derivative position originated from a capital markets transaction, rather than employee compensation, and ties the warrants directly to that earlier financing event.
Evaxion AS

NASDAQ:EVAX

View EVAX Stock Overview

EVAX Rankings

EVAX Latest News

EVAX Latest SEC Filings

EVAX Stock Data

33.36M
6.88M
Biotechnology
Healthcare
Link
Denmark
Horsholm